Page last updated: 2024-11-12

imidazoleacetic acid ribotide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

imidazoleacetic acid ribotide: metabolite of imidazole acetic acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16019958
CHEBI ID16805
MeSH IDM0249565

Synonyms (15)

Synonym
[1-(5-phosphoribosyl)imidazol-4-yl]acetic acid
CHEBI:16805 ,
[1-(5-phosphoribofuranosyl)imidazol-4-yl]acetic acid
imidazoleacetic acid ribotide
2-[1-[(3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazol-4-yl]acetic acid
2-{1-[(3r,4s,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1h-imidazol-4-yl}acetic acid
1-ribosylimidazole-4-acetic acid 5'-phosphate
1-b-d-ribofuranosyl-imidazole-4-acetic acid 5'-phosphate
imidazole-4-acetic acid ribotide
1-b-d-ribofuranosyl-imidazole-4-acetic acid 5'-(dihydrogen phosphate)
1-(5-o-phosphono-b-d-ribofuranosyl)-1h-imidazole-4-acetic acid
1-(5-o-phosphono-beta-delta-ribofuranosyl)-1h-imidazole-4-acetic acid
1-beta-delta-ribofuranosyl-imidazole-4-acetic acid 5'-(dihydrogen phosphate)
1-beta-delta-ribofuranosyl-imidazole-4-acetic acid 5'-phosphate
Q27102082
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
N-glycosyl compoundA glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a nitrogen atom, thus creating a C-N bond.
ribose monophosphate
imidazolesA five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's5 (50.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]